Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
May 16, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 16, 2024 (GLOBE NEWSWIRE) -- Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight...
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
May 16, 2024 08:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa VELA is the first Phase 3 program in hidradenitis...
JD.com Announces First Quarter 2024 Results
May 16, 2024 06:00 ET
|
JD.com, Inc.
BEIJING, May 16, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the “Company”), a leading supply chain-based technology and service provider,...
Type 1 Diabetes Market Size to Worth USD 24.36 Bn By 2031
May 16, 2024 05:30 ET
|
CMI
Burlingame, May 16, 2024 (GLOBE NEWSWIRE) -- The global type 1 diabetes market is estimated to be valued at USD 15.95 Bn in 2024 and is expected to reach USD 24.36 Bn by 2031, according to Coherent...
JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies - Eli Lilly and Company, Incyte Corporation, Dompé Farmaceutici S.p.A, Sanofi, Celgene, AstraZeneca, Karyopharm Therapeutics
May 15, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 15, 2024 (GLOBE NEWSWIRE) -- JAK Inhibitor Market to Register Immense Growth by 2034, Predicts DelveInsight | Key Companies - Eli Lilly and Company, Incyte Corporation, Dompé...
Topical Drug Delivery Market Size to Hit USD 229.91 Bn by 2031
May 15, 2024 11:54 ET
|
CMI
Burlingame, May 15, 2024 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global topical drug delivery market is estimated to be valued at US$ 88.54 Bn in 2022 and is expected to...
RNAi Therapeutics Market Size Expected to Reach USD 4.28 Bn by 2033
May 15, 2024 11:02 ET
|
Precedence Research
Ottawa, May 15, 2024 (GLOBE NEWSWIRE) -- The global RNAi therapeutics market size was valued at USD 1.11 billion in 2023 and is predicted to hit around USD 3.61 billion by 2032, a study published by...
Arachnoiditis Market To Reach USD 3.3 Billion By 2032 | DataHorizzon Research
May 14, 2024 03:17 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 14, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of chronic pain is projected to encourage market developments. The arachnoiditis market is propelled by the...
Global Cell Therapy and Gene Therapy Market Report 2023-2029
May 13, 2024 11:34 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029" report has been added to ResearchAndMarkets.com's offering.A newly released...
Global Preventive Vaccines Market Size To Exceed USD 101.22 Billion By 2033 | CAGR Of 1.37%
May 13, 2024 10:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, May 13, 2024 (GLOBE NEWSWIRE) -- The Global Preventive Vaccines Market Size is to Grow from USD 88.34 Billion in 2023 to USD 101.22 Billion by 2033, at a Compound Annual...